Psychedelics in Therapy
The discussion highlights the groundbreaking potential of psychedelics like ketamine and psilocybin in treating conditions such as treatment-resistant depression and PTSD. While these therapies can lead to long-lasting improvements, the pharmaceutical industry faces challenges due to the inability to patent these substances, which limits profit potential. The contrast between traditional antidepressants and psychedelics raises critical questions about the motivations behind mental health treatments.In this clip
From this podcast
Mind Pump Podcast
Improve Your Health By Questioning What's "Normal" | Mind Pump 2254
Related Questions